Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Patterson

Showing results (131-140 of 277) with videos related to

Pageof 28
Sort By:
Protein Engineering, Design & Selection : PEDS|July 6, 2014
Toward a high-throughput screening platform for directed evolution of enzymes that activate genotoxic prodrugsJ N Copp, E M Williams, M H Rich, et al.
British Journal of Cancer|December 10, 1999
Does reductive metabolism predict response to tirapazamine (SR 4233) in human non-small-cell lung cancer cell lines?E C Chinje, A V Patterson, M P Saunders, et al.
Cancer Chemotherapy and Pharmacology|December 17, 2009
A phase I trial of PR-104, a nitrogen mustard prodrug activated by both hypoxia and aldo-keto reductase 1C3, in patients with solid tumorsMichael B Jameson, Danny Rischin, Mark Pegram, et al.
British Journal of Cancer|September 1, 1995
Increased sensitivity to the prodrug 5'-deoxy-5-fluorouridine and modulation of 5-fluoro-2'-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylaseA V Patterson, H Zhang, A Moghaddam, et al.
Radiation Research|May 26, 2007
Bystander effects of bioreductive drugs: potential for exploiting pathological tumor hypoxia with dinitrobenzamide mustardsWilliam R Wilson, Kevin O Hicks, Susan M Pullen, et al.
Environmental Science & Technology|October 12, 2021
Computational Approaches for the Prediction of Environmental Transformation Products: Chlorination of Steroidal EnonesChristopher J Knutson, Nicholas C Pflug, Wyanna Yeung, et al.
The Journal of Biological Chemistry|November 8, 2013
Zinc finger nuclease knock-out of NADPH:cytochrome P450 oxidoreductase (POR) in human tumor cell lines demonstrates that hypoxia-activated prodrugs differ in POR dependenceJiechuang Su, Yongchuan Gu, Frederik B Pruijn, et al.
International Journal of Radiation Oncology, Biology, Physics|September 18, 2007
Oxygen dependence and extravascular transport of hypoxia-activated prodrugs: comparison of the dinitrobenzamide mustard PR-104A and tirapazamineKevin O Hicks, Hilary Myint, Adam V Patterson, et al.
The Journal of Gene Medicine|May 12, 2012
Single agent- and combination treatment with two targeted suicide gene therapy systems is effective in chemoresistant small cell lung cancer cellsSigne R Michaelsen, Camilla L Christensen, Maxwell Sehested, et al.
Journal of Gerontology|July 1, 1980
Age differences in the contingent negative variation (CNV): reduced frontal activity in the elderlyH J Michalewski, L W Thompson, D B Smith, et al.
Pageof 28

Showing results (131-140 of 277) with videos related to

Sort By:
Pageof 28
Protein Engineering, Design & Selection : PEDS|July 6, 2014
Toward a high-throughput screening platform for directed evolution of enzymes that activate genotoxic prodrugsJ N Copp, E M Williams, M H Rich, et al.
British Journal of Cancer|December 10, 1999
Does reductive metabolism predict response to tirapazamine (SR 4233) in human non-small-cell lung cancer cell lines?E C Chinje, A V Patterson, M P Saunders, et al.
Cancer Chemotherapy and Pharmacology|December 17, 2009
A phase I trial of PR-104, a nitrogen mustard prodrug activated by both hypoxia and aldo-keto reductase 1C3, in patients with solid tumorsMichael B Jameson, Danny Rischin, Mark Pegram, et al.
British Journal of Cancer|September 1, 1995
Increased sensitivity to the prodrug 5'-deoxy-5-fluorouridine and modulation of 5-fluoro-2'-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylaseA V Patterson, H Zhang, A Moghaddam, et al.
Radiation Research|May 26, 2007
Bystander effects of bioreductive drugs: potential for exploiting pathological tumor hypoxia with dinitrobenzamide mustardsWilliam R Wilson, Kevin O Hicks, Susan M Pullen, et al.
Environmental Science & Technology|October 12, 2021
Computational Approaches for the Prediction of Environmental Transformation Products: Chlorination of Steroidal EnonesChristopher J Knutson, Nicholas C Pflug, Wyanna Yeung, et al.
The Journal of Biological Chemistry|November 8, 2013
Zinc finger nuclease knock-out of NADPH:cytochrome P450 oxidoreductase (POR) in human tumor cell lines demonstrates that hypoxia-activated prodrugs differ in POR dependenceJiechuang Su, Yongchuan Gu, Frederik B Pruijn, et al.
International Journal of Radiation Oncology, Biology, Physics|September 18, 2007
Oxygen dependence and extravascular transport of hypoxia-activated prodrugs: comparison of the dinitrobenzamide mustard PR-104A and tirapazamineKevin O Hicks, Hilary Myint, Adam V Patterson, et al.
The Journal of Gene Medicine|May 12, 2012
Single agent- and combination treatment with two targeted suicide gene therapy systems is effective in chemoresistant small cell lung cancer cellsSigne R Michaelsen, Camilla L Christensen, Maxwell Sehested, et al.
Journal of Gerontology|July 1, 1980
Age differences in the contingent negative variation (CNV): reduced frontal activity in the elderlyH J Michalewski, L W Thompson, D B Smith, et al.
Pageof 28